Pacira BioSciences, Inc. (PCRX)
USD 24.97
(1.67%)
USD 24.97
(1.67%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.91 USD | 160.0% |
| 2022 | 0.35 USD | -63.16% |
| 2021 | 0.95 USD | -72.14% |
| 2020 | 3.41 USD | 1362.96% |
| 2019 | -0.27 USD | -2247.83% |
| 2018 | -0.01 USD | 98.93% |
| 2017 | -1.07 USD | -4.9% |
| 2016 | -1.02 USD | -2140.0% |
| 2015 | 0.05 USD | 112.82% |
| 2014 | -0.39 USD | 79.79% |
| 2013 | -1.93 USD | -12.21% |
| 2012 | -1.72 USD | 34.85% |
| 2011 | -2.64 USD | -67.09% |
| 2010 | -1.58 USD | 97.14% |
| 2009 | -55.32 USD | 30.18% |
| 2008 | -79.23 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.41 USD | 115.79% |
| 2024 Q1 | 0.19 USD | -64.81% |
| 2023 Q3 | 0.23 USD | -58.93% |
| 2023 Q4 | 0.54 USD | 134.78% |
| 2023 FY | - USD | 160.0% |
| 2023 Q2 | 0.56 USD | 230.23% |
| 2023 Q1 | -0.43 USD | -95.45% |
| 2022 Q4 | -0.22 USD | -1356.95% |
| 2022 Q2 | 0.40 USD | 166.67% |
| 2022 Q1 | 0.15 USD | 225.0% |
| 2022 FY | - USD | -63.16% |
| 2022 Q3 | -0.02 USD | -103.78% |
| 2021 Q2 | 0.43 USD | 79.17% |
| 2021 Q1 | 0.24 USD | -27.27% |
| 2021 Q4 | -0.12 USD | -130.0% |
| 2021 Q3 | 0.40 USD | -6.98% |
| 2021 FY | - USD | -72.14% |
| 2020 Q1 | 0.19 USD | 258.33% |
| 2020 FY | - USD | 1362.96% |
| 2020 Q2 | -0.17 USD | -189.47% |
| 2020 Q3 | 3.03 USD | 1882.35% |
| 2020 Q4 | 0.33 USD | -89.11% |
| 2019 Q4 | -0.12 USD | 20.0% |
| 2019 Q2 | 0.07 USD | 200.0% |
| 2019 Q3 | -0.15 USD | -314.29% |
| 2019 FY | - USD | -2247.83% |
| 2019 Q1 | -0.07 USD | -135.0% |
| 2018 Q3 | -0.02 USD | -126.0% |
| 2018 Q1 | -0.26 USD | -336.36% |
| 2018 FY | - USD | 98.93% |
| 2018 Q4 | 0.20 USD | 1382.05% |
| 2018 Q2 | 0.06 USD | 123.08% |
| 2017 FY | - USD | -4.9% |
| 2017 Q4 | 0.11 USD | 157.89% |
| 2017 Q3 | -0.19 USD | 61.22% |
| 2017 Q2 | -0.49 USD | 5.77% |
| 2017 Q1 | -0.52 USD | -372.73% |
| 2016 Q4 | -0.11 USD | 81.36% |
| 2016 Q2 | -0.21 USD | -110.0% |
| 2016 Q1 | -0.10 USD | -47.28% |
| 2016 FY | - USD | -2140.0% |
| 2016 Q3 | -0.59 USD | -180.95% |
| 2015 Q1 | 0.03 USD | -81.25% |
| 2015 Q4 | -0.07 USD | -184.88% |
| 2015 FY | - USD | 112.82% |
| 2015 Q3 | 0.08 USD | 39900.0% |
| 2015 Q2 | 0.00 USD | -99.33% |
| 2014 Q4 | 0.16 USD | 291.39% |
| 2014 FY | - USD | 79.79% |
| 2014 Q3 | -0.08 USD | 40.29% |
| 2014 Q2 | -0.14 USD | 58.82% |
| 2014 Q1 | -0.34 USD | 5.56% |
| 2013 Q4 | -0.36 USD | 18.18% |
| 2013 Q1 | -0.71 USD | -39.22% |
| 2013 FY | - USD | -12.21% |
| 2013 Q2 | -0.42 USD | 40.85% |
| 2013 Q3 | -0.44 USD | -4.76% |
| 2012 Q2 | -0.27 USD | 42.55% |
| 2012 Q1 | -0.47 USD | 21.67% |
| 2012 Q3 | -0.49 USD | -81.48% |
| 2012 Q4 | -0.51 USD | -4.08% |
| 2012 FY | - USD | 34.85% |
| 2011 FY | - USD | -67.09% |
| 2011 Q1 | -0.98 USD | 92.02% |
| 2011 Q2 | -0.51 USD | 47.96% |
| 2011 Q3 | -0.55 USD | -7.84% |
| 2011 Q4 | -0.60 USD | -9.09% |
| 2010 Q4 | -12.28 USD | 10.82% |
| 2010 Q3 | -13.77 USD | -16.1% |
| 2010 Q2 | -11.86 USD | -26.3% |
| 2010 Q1 | -9.39 USD | 39.92% |
| 2010 FY | - USD | 97.14% |
| 2009 Q3 | -11.49 USD | 0.0% |
| 2009 Q4 | -15.63 USD | -36.03% |
| 2009 FY | - USD | 30.18% |
| 2008 FY | - USD | 0.0% |